Literature DB >> 19804513

Comparison between contrast-enhanced magnetic resonance imaging and Selvester QRS scoring system in estimating changes in infarct size between the acute and chronic phases of myocardial infarction.

Daniël A Geerse1, Katherine C Wu, Anton P Gorgels, Jeffrey Zimmet, Galen S Wagner, Julie M Miller.   

Abstract

BACKGROUND: The Selvester QRS score was developed as a method to estimate infarct size (IS) using the ECG and has been validated during the prereperfusion era. Few comparisons exist with contrast-enhanced magnetic resonance imaging (ceMRI) in reperfused patients. This study evaluates the ability of the Selvester QRS score to estimate serial changes in IS during the acute and chronic phases of the infarct evolution in patients who have received reperfusion therapy.
METHODS: Thirteen patients with acute myocardial infarction underwent serial ceMRI studies in the acute (<1 week) and chronic phase (>2 months) after their initial myocardial infarction. QRS scoring was performed on the corresponding ECGs. The correlation between ceMRI measurement and QRS score estimation of IS was determined at both time points and for the difference between the two phases.
RESULTS: The mean IS was 20.1 +/- 11.0% of total left ventricular mass (% LV) in the acute phase and 13.3 +/- 6.4% LV in the chronic phase ceMRI. The mean IS estimated by Selvester QRS score in the acute and chronic phases were 18.7 +/- 8.2% and 16.4 +/- 8.5% LV, respectively. A modest correlation was found for the acute (r = 0.57) and chronic phase IS (r = 0.54). However, there was no correlation for the difference in IS between the acute and chronic phases.
CONCLUSIONS: In this pilot study, the Selvester QRS score correlates modestly to IS by ceMRI during both the acute and chronic phases of the infarction process. The serial changes over time in the Selvester QRS score and IS by ceMRI show no correlation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804513      PMCID: PMC6932321          DOI: 10.1111/j.1542-474X.2009.00327.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  24 in total

1.  Death rates from coronary disease--progress and a puzzling paradox.

Authors:  D Levy; T J Thom
Journal:  N Engl J Med       Date:  1998-09-24       Impact factor: 91.245

2.  Size and transmural extent of first-time reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12-lead electrocardiogram.

Authors:  Henrik Engblom; Erik Hedström; Einar Heiberg; Galen S Wagner; Olle Pahlm; Håkan Arheden
Journal:  Am Heart J       Date:  2005-11       Impact factor: 4.749

3.  Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle.

Authors:  U S Pahlm; B R Chaitman; P M Rautaharju; R H Selvester; G S Wagner
Journal:  Am J Cardiol       Date:  1998-04-01       Impact factor: 2.778

4.  Total excitation of the isolated human heart.

Authors:  D Durrer; R T van Dam; G E Freud; M J Janse; F L Meijler; R C Arzbaecher
Journal:  Circulation       Date:  1970-06       Impact factor: 29.690

5.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model.

Authors:  Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

Review 6.  Reperfusion treatment of ST-elevation acute myocardial infarction.

Authors:  Flavio Ribichini; Valeria Ferrero; William Wijns
Journal:  Prog Cardiovasc Dis       Date:  2004 Sep-Oct       Impact factor: 8.194

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

8.  Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts.

Authors:  S F Roark; R E Ideker; G S Wagner; D R Alonso; S P Bishop; C M Bloor; D A Bramlet; J E Edwards; J T Fallon; G J Gottlieb; D B Hackel; H R Phillips; K A Reimer; W J Rogers; W K Ruth; R M Savage; R D White; R H Selvester
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

9.  Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts.

Authors:  R E Ideker; G S Wagner; W K Ruth; D R Alonso; S P Bishop; C M Bloor; J T Fallon; G J Gottlieb; D B Hackel; H R Phillips; K A Reimer; S F Roark; W J Rogers; R M Savage; R D White; R H Selvester
Journal:  Am J Cardiol       Date:  1982-05       Impact factor: 2.778

Review 10.  Infarct size as a determinant of acute and long-term prognosis.

Authors:  E M Geltman
Journal:  Cardiol Clin       Date:  1984-02       Impact factor: 2.213

View more
  6 in total

1.  Differences in the Selvester QRS score after primary PCI strategy and conservative treatment for STEMI patients with negative T waves.

Authors:  Egle Kalinauskiene; Dalia Gerviene; Ljuba Bacharova; Zora Krivosikova; Albinas Naudziunas
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-08-01       Impact factor: 1.468

2.  Selvester QRS score and total perfusion deficit calculated by quantitative gated single-photon emission computed tomography in patients with prior anterior myocardial infarction in the coronary intervention era.

Authors:  Satoshi Kurisu; Takashi Shimonaga; Hiroki Ikenaga; Noriaki Watanabe; Tadanao Higaki; Ken Ishibashi; Yoshihiro Dohi; Yukihiro Fukuda; Yasuki Kihara
Journal:  Heart Vessels       Date:  2016-08-03       Impact factor: 2.037

3.  Automatically computed ECG algorithm for the quantification of myocardial scar and the prediction of mortality.

Authors:  Patrick Badertscher; Ivo Strebel; Ursina Honegger; Nicolas Schaerli; Deborah Mueller; Christian Puelacher; Max Wagener; Roger Abächerli; Joan Walter; Zaid Sabti; Lorraine Sazgary; Stella Marbot; Jeanne du Fay de Lavallaz; Raphael Twerenbold; Jasper Boeddinghaus; Thomas Nestelberger; Nikola Kozhuharov; Tobias Breidthardt; Samyut Shrestha; Dayana Flores; Carmela Schumacher; Damian Wild; Stefan Osswald; Michael J Zellweger; Christian Mueller; Tobias Reichlin
Journal:  Clin Res Cardiol       Date:  2018-04-17       Impact factor: 5.460

4.  Q wave area for stratification of global left ventricular infarct size: comparison to conventional ECG assessment using Selvester QRS-score.

Authors:  Jonathan W Weinsaft; Jonathan D Kochav; Anika Afroz; Peter M Okin
Journal:  Coron Artery Dis       Date:  2014-03       Impact factor: 1.439

5.  Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction.

Authors:  Li Zhang; Miao Hu; Yuan Chen; Yijun Wang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

6.  Decreases in electrocardiographic R-wave amplitude and QT interval predict myocardial ischemic infarction in Rhesus monkeys with left anterior descending artery ligation.

Authors:  Xiaorong Sun; Jindan Cai; Xin Fan; Pengfei Han; Yuping Xie; Jianmin Chen; Ying Xiao; Y James Kang
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.